BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34614191)

  • 1. Streamlined CRISPR genome engineering in wild-type bacteria using SIBR-Cas.
    Patinios C; Creutzburg SCA; Arifah AQ; Adiego-Pérez B; Gyimah EA; Ingham CJ; Kengen SWM; van der Oost J; Staals RHJ
    Nucleic Acids Res; 2021 Nov; 49(19):11392-11404. PubMed ID: 34614191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targetron-Assisted Delivery of Exogenous DNA Sequences into
    Velázquez E; Al-Ramahi Y; Tellechea-Luzardo J; Krasnogor N; de Lorenzo V
    ACS Synth Biol; 2021 Oct; 10(10):2552-2565. PubMed ID: 34601868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of ssDNA recombineering and CRISPR-Cas9 for Pseudomonas putida KT2440 genome editing.
    Wu Z; Chen Z; Gao X; Li J; Shang G
    Appl Microbiol Biotechnol; 2019 Mar; 103(6):2783-2795. PubMed ID: 30762073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing and transcriptional repression in Pseudomonas putida KT2440 via the type II CRISPR system.
    Sun J; Wang Q; Jiang Y; Wen Z; Yang L; Wu J; Yang S
    Microb Cell Fact; 2018 Mar; 17(1):41. PubMed ID: 29534717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
    Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
    Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RiboCas: A Universal CRISPR-Based Editing Tool for Clostridium.
    Cañadas IC; Groothuis D; Zygouropoulou M; Rodrigues R; Minton NP
    ACS Synth Biol; 2019 Jun; 8(6):1379-1390. PubMed ID: 31181894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular (de)construction of complex bacterial phenotypes by CRISPR/nCas9-assisted, multiplex cytidine base-editing.
    Volke DC; Martino RA; Kozaeva E; Smania AM; Nikel PI
    Nat Commun; 2022 May; 13(1):3026. PubMed ID: 35641501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli.
    Zerbini F; Zanella I; Fraccascia D; König E; Irene C; Frattini LF; Tomasi M; Fantappiè L; Ganfini L; Caproni E; Parri M; Grandi A; Grandi G
    Microb Cell Fact; 2017 Apr; 16(1):68. PubMed ID: 28438207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of different types of CRISPR/Cas-based systems in bacteria.
    Liu Z; Dong H; Cui Y; Cong L; Zhang D
    Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 Editing of the Synthesis of Biodegradable Polyesters Polyhydroxyalkanaotes (PHA) in Pseudomonas putida KT2440.
    Liu S; Narancic T; Davis C; O'Connor KE
    Methods Mol Biol; 2022; 2397():341-358. PubMed ID: 34813072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted editing and evolution of engineered ribosomes in vivo by filtered editing.
    Radford F; Elliott SD; Schepartz A; Isaacs FJ
    Nat Commun; 2022 Jan; 13(1):180. PubMed ID: 35013328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9.
    Iwasaki RS; Ozdilek BA; Garst AD; Choudhury A; Batey RT
    Nat Commun; 2020 Mar; 11(1):1394. PubMed ID: 32170140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Reach of Recombineering to Environmental Bacteria.
    Borrero-de Acuña JM; Poblete-Castro I
    Trends Biotechnol; 2020 Jul; 38(7):684-685. PubMed ID: 32312593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombination-Independent Genome Editing through CRISPR/Cas9-Enhanced TargeTron Delivery.
    Velázquez E; Lorenzo V; Al-Ramahi Y
    ACS Synth Biol; 2019 Sep; 8(9):2186-2193. PubMed ID: 31419111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Genome Editing of Virulent Pseudomonas Phages Using CRISPR-Cas3.
    Schroven K; Voet M; Lavigne R; Hendrix H
    Methods Mol Biol; 2024; 2793():113-128. PubMed ID: 38526727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Assisted Seamless Genome Editing in Lactobacillus plantarum and Its Application in
    Zhou D; Jiang Z; Pang Q; Zhu Y; Wang Q; Qi Q
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444197
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic engineering of Escherichia coli BL21 strain using simplified CRISPR-Cas9 and asymmetric homology arms recombineering.
    Shukal S; Lim XH; Zhang C; Chen X
    Microb Cell Fact; 2022 Feb; 21(1):19. PubMed ID: 35123478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.